References of "Lemaire, Christian"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailSYNTHESIS OF NONACTIVATED F-18 FLUORINATED AROMATIC-COMPOUNDS THROUGH NUCLEOPHILIC-SUBSTITUTION AND DECARBOXYLATION REACTIONS
Plenevaux, Alain ULg; Lemaire, Christian ULg; Palmer, Anthtony J. et al

in Applied Radiation & Isotopes (1992), 43(8), 1035-1040

The synthesis of no-carrier-added 3-[F-18]fluoroanisole, 2-[F-18]fluoroanisole, [F-18]fluorobenzene and 4-[F-18]fluoroveratrole are reported. The strategy consists of amino-polyether supported ... [more ▼]

The synthesis of no-carrier-added 3-[F-18]fluoroanisole, 2-[F-18]fluoroanisole, [F-18]fluorobenzene and 4-[F-18]fluoroveratrole are reported. The strategy consists of amino-polyether supported nucleophilic substitution with [F-18]F- on activated nitro aromatic aldehyde precursors followed by decarbonylation using Tris(triphenylphosphine) rhodium (I) chloride. The experimental parameters for this reaction have been studied and optimized with 2-[F-18]fluoro-4-methoxybenzaldehyde and then successfully applied to four other F-18-fluorinated aromatic aldehydes. The decarbonylation yields obtained were 84 +/- 5% (corrected for decay) within 15 min at 150-degrees-C in 1,4-dioxan. [less ▲]

Detailed reference viewed: 33 (4 ULg)
Full Text
Peer Reviewed
See detail2- and 4-[18F]fluorotropapride, two specific D2 receptor ligands for positron emission tomography: N.C.A. syntheses and animal studies.
Damhaut, Philippe; Cantineau, Robert; Lemaire, Christian ULg et al

in International Journal of Radiation Applications and Instrumentation. Part A : Applied Radiation and Isotopes (1992), 43(10), 1265-74

Tropapride, (exo)-2,3-dimethoxy-N-[8-(phenylmethyl)-8- azabicyclo[3.2.1]oct-3-yl]benzamide hydrochloride, has been labeled with fluorine-18 at the 2- and 4-positions of its benzylic group. Two synthetic ... [more ▼]

Tropapride, (exo)-2,3-dimethoxy-N-[8-(phenylmethyl)-8- azabicyclo[3.2.1]oct-3-yl]benzamide hydrochloride, has been labeled with fluorine-18 at the 2- and 4-positions of its benzylic group. Two synthetic pathways were investigated: the first one required the alkylation of the norbenzyl precursor with 2- or 4-[18F]fluorobenzyl bromide (radiochemical yield of 5% EOB, 180 min); the second method consisted of a reductive amination of norbenzyl tropapride with 2- or 4-[18F]fluorobenzaldehyde (20% EOB, 110 min). In both cases, the specific activity was found to be greater than 1 Ci/mumol (EOS). Animal studies in rats showed the percentage of the injected dose localizing in the whole brain to be 0.6 +/- 0.09 and 0.2 +/- 0.03 at 2 h post injection for the para- and the ortho-[18F]fluoro analogs of tropapride respectively. Cerebral biodistribution studies showed at 4 h a striatum uptake of 5 +/- 0.7% of the injected dose per gram of striatum for the para derivative with a low fixation into the frontal cortex and the cerebellum (% ID/g FC < 0.4 and % ID/g Cb < 0.3). The selectivity of 4-[18F]fluorotropapride for D2 dopaminergic sites was demonstrated through blocking experiments with ketanserin, spiperone and halopemide. The saturability was confirmed by the use of variable specific activities. These preliminary results showed that 4-[18F]fluorotropapride can be considered as a potent radiopharmaceutical for the study of the dopaminergic system with PET. [less ▲]

Detailed reference viewed: 33 (13 ULg)
Peer Reviewed
See detailDecrease of frontal metabolism demonstrated by positron emission tomography in a population of healthy elderly volunteers.
Salmon, Eric ULg; Maquet, Pierre ULg; Sadzot, Bernard ULg et al

in Acta Neurologica Belgica (1991), 91(5), 288-95

Frontal metabolism measured with positron emission tomography is shown to be decreased relatively to that in other cortical or sub-cortical areas, in a population of healthy elderly compared to young ... [more ▼]

Frontal metabolism measured with positron emission tomography is shown to be decreased relatively to that in other cortical or sub-cortical areas, in a population of healthy elderly compared to young volunteers. Cortical atrophy or neuronal depopulation are unlikely to entirely explain this physiological phenomenon, and sub-cortico-cortical deactivation should play a role, analogous to that proposed in subcortical diseases. [less ▲]

Detailed reference viewed: 9 (0 ULg)
Peer Reviewed
See detailChemical processing for the production of carrier free selenium-73 from germanium and arsenic targets and synthesis of L-[73Se]selenomethionine.
Plenevaux, Alain ULg; Guillaume, M.; Brihaye, C. et al

in Journal of Labelled Compounds & Radiopharmaceuticals (1991), 30

Detailed reference viewed: 5 (1 ULg)
Full Text
Peer Reviewed
See detailNCA synthesis of an N-w-[18F]fluoroethyl analog of altanserine, a serotonine S2 receptor ligand.
Lemaire, Christian ULg; Damhaut, Ph.; Cantineau, R. et al

in Journal of Labelled Compounds & Radiopharmaceuticals (1991), 30

Detailed reference viewed: 15 (0 ULg)
Full Text
Peer Reviewed
See detailRoutine production and improvement in the purification of 3-N-(2'-[18F]fluoroethyl)spiperone for clinical use.
Plenevaux, Alain ULg; Cantineau, R.; Labar, D. et al

in Journal of Labelled Compounds & Radiopharmaceuticals (1991), 30

Detailed reference viewed: 7 (0 ULg)
Full Text
Peer Reviewed
See detailNCA asymmetric synthesis of 6-[18F]fluoro-L-dopa.
Lemaire, Christian ULg; Guillaume, M.; Cantineau, R. et al

in Journal of Labelled Compounds & Radiopharmaceuticals (1991), 30

Detailed reference viewed: 10 (1 ULg)
Full Text
Peer Reviewed
See detail18F-substituted aromatic aldehydes, key intermediates for nca radiosyntheses.
Lemaire, Christian ULg; Guillaume, M.; Plenevaux, Alain ULg et al

in Journal of Labelled Compounds & Radiopharmaceuticals (1991), 30

Detailed reference viewed: 20 (0 ULg)
Full Text
Peer Reviewed
See detailSynthesis and preliminary animal studies of [131I]iodotropapride: a cerebral dopamine D2 receptor ligand.
Cantineau, R.; Damhaut, Ph.; Plenevaux, Alain ULg et al

in Journal of Labelled Compounds & Radiopharmaceuticals (1991), 30

Detailed reference viewed: 9 (1 ULg)
Peer Reviewed
See detailAsymmetric synthesis of 4-[18F]fluoro-L-m-tyrosine via aromatic fluorination.
Lemaire, Christian ULg; Damhaut, Ph.; Plenevaux, Alain ULg et al

in Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine (1991), 32

Detailed reference viewed: 15 (1 ULg)
Peer Reviewed
See detailSerotonine-S2 receptor imaging with [18F]altanserin and PET. Results in young normal controls.
Sadzot, Bernard ULg; Lemaire, Christian ULg; Cantineau, R. et al

in Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine (1991), 32

Detailed reference viewed: 17 (1 ULg)
Peer Reviewed
See detail4-[18F]Fluorotropapride, a specific D2 receptor ligand for PET.
Damhaut, Ph.; Cantineau, R.; Lemaire, Christian ULg et al

in Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine (1991), 32

Detailed reference viewed: 6 (1 ULg)
Peer Reviewed
See detail2 and 4-[18F]fluorotropapride, two specific D2 receptor ligand for PET.
Damhaut, Ph.; Cantineau, R.; Lemaire, Christian ULg et al

in European Journal of Nuclear Medicine (1991), 18

Detailed reference viewed: 9 (1 ULg)
Full Text
Peer Reviewed
See detailAN APPROACH TO THE ASYMMETRIC-SYNTHESIS OF L-6-[F-18]FLUORODOPA VIA NCA NUCLEOPHILIC FLUORINATION
Lemaire, Christian ULg; Guillaume, Marcel; Cantineau, Robert et al

in Applied Radiation & Isotopes (1991), 42(7), 629-635

The NCA asymmetric synthesis of L-6-[F-18]fluorodopa starting from (1R,2R,5R)-[(+)-2-hydroxypinanyl-3-idene]glycine t-butyl ester as chiral agent has been developed. After F-18-fluorination of the two ... [more ▼]

The NCA asymmetric synthesis of L-6-[F-18]fluorodopa starting from (1R,2R,5R)-[(+)-2-hydroxypinanyl-3-idene]glycine t-butyl ester as chiral agent has been developed. After F-18-fluorination of the two commercially available aldehydes either 6-nitroveratraldehyde or 6-nitropiperonal, the required alkylating [F-18]fluorobenzyl bromide derivative can be easily prepared by treatment with NaBH4 followed by SOBr2. Alkylation of the Schiff base was carried out with the lithium salt of 2,2,6,6-tetramethylpiperidine as base in anhydrous THF at -78-degrees-C. Following hydrolysis of the protecting groups with hydroxylamine and Hl, the L-amino acid was obtained in 75% L form (ee 50%) with a 10% decay corrected (120 min) radiochemical yield. [less ▲]

Detailed reference viewed: 29 (2 ULg)
Full Text
Peer Reviewed
See detailFluorine-18-altanserin: a radioligand for the study of serotonin receptors with PET: radiolabeling and in vivo biologic behavior in rats.
Lemaire, Christian ULg; Cantineau, Robert; Guillaume, Marcel et al

in Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine (1991), 32(12), 2266-72

No-carrier-added [18F]altanserin was synthesized by nucleophilic substitution of the corresponding nitro compound with [18F]fluoride in the presence of kryptofix 222 and K2CO3. After purification by ... [more ▼]

No-carrier-added [18F]altanserin was synthesized by nucleophilic substitution of the corresponding nitro compound with [18F]fluoride in the presence of kryptofix 222 and K2CO3. After purification by preparative HPLC, [18F]altanserin was produced in less than 2 hr with a radiochemical yield of 10% (EOS) and a specific activity of 0.8-1.3 Ci/mumol. In rats, the tracer localized rapidly in the whole brain (0.5% ID/g organ) with a high binding to the frontal cortex. The frontal cortex/cerebellum ratio increased with time and reached a plateau of 11 at 2 hr postinjection. This uptake in S2 receptor regions was saturable and could be blocked by pretreatment with various S2 antagonists. This radiopharmaceutical appears to be more selective for S2 receptor sites than other ligands available today and allows the study of S2 receptors under in vivo conditions. [less ▲]

Detailed reference viewed: 23 (4 ULg)
Peer Reviewed
See detail[131I]iodotropapride: a cerebral dopamine D2 receptor ligand.
Cantineau, R.; Damhaut, Ph; Plenevaux, Alain ULg et al

Poster (1990, August 26)

Detailed reference viewed: 13 (3 ULg)
Peer Reviewed
See detailImaging serotonin-S2 receptors in humans with PET and the selective S2 antagonist [18F]altanserin. Preliminary results.
Sadzot, Bernard ULg; Lemaire, Christian ULg; Cantineau, R. et al

in Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine (1990, June 19), 31

Detailed reference viewed: 11 (2 ULg)
Full Text
Peer Reviewed
See detailSynthesis and tissue distribution of four Se-labeled tertiary amines, potential brain pH imaging agents.
Plenevaux, Alain ULg; Cantineau, Robert; Brihaye, Claude et al

in International Journal of Radiation Applications and Instrumentation. Part B : Nuclear Medicine and Biology (1990), 17(6), 601-7

Four new tertiary amines: bis(3-N,N-dimethyl aminopropyl)selenide (PROMOSE), bis(3-N-(morpholino)propyl)selenide, N-methyl-selenomorpholine and N-phenyl-selenomorpholine structurally related to MOSE ... [more ▼]

Four new tertiary amines: bis(3-N,N-dimethyl aminopropyl)selenide (PROMOSE), bis(3-N-(morpholino)propyl)selenide, N-methyl-selenomorpholine and N-phenyl-selenomorpholine structurally related to MOSE proposed by Kung and Blau, have been labeled through a radiochemical procedure suitable for both 75Se and 73Se. The radiochemical yields of the carrier added synthesis ranged between 64 and 85% for the four 75Se labelings and was 64% EOB time corrected for [73Se]PROMOSE. The chemical and radiochemical purities were higher than 99% after chromatographic purifications. The n-octanol/phosphate buffer partition coefficients (P) were measured at various pH (6.5-8) for each compound and the tissue distributions of PROMOSE in rats were also carried out. The experimental results showed a good correlation between the P = f(pH) function and the in vivo behaviour of the considered compound. PROMOSE was selected for further investigations as a brain pH indicator. [less ▲]

Detailed reference viewed: 24 (2 ULg)
Peer Reviewed
See detailNo-carrier-added regioselective preparation of 6-[18F]fluoro-L-dopa
Lemaire, Christian ULg; Guillaume, Marcel ULg; Cantineau, Robert et al

in Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine (1990), 31(7), 1247-1251

Detailed reference viewed: 11 (3 ULg)